Tandem Diabetes Care, Inc.

Equities

TNDM

US8753722037

Medical Equipment, Supplies & Distribution

Market Closed - Nasdaq 04:00:00 2024-04-19 pm EDT 5-day change 1st Jan Change
30.43 USD -1.62% Intraday chart for Tandem Diabetes Care, Inc. -9.16% +2.87%

This article is reserved for members

Already a member?

Log In

Not a member ?

Free registration
North American Morning Briefing : Stocks Edge -2- DJ
Tandem Diabetes Care Shares Rise After Stifel Upgrade MT
Stifel Upgrades Tandem Diabetes Care to Buy From Hold, Adjusts Price Target to $37 From $24 MT
Citigroup Raises Price Target on Tandem Diabetes Care to $31 From $25, Keeps Neutral Rating MT
Transcript : Tandem Diabetes Care, Inc. Presents at Barclays 26th Annual Global Healthcare Conference 2024, Mar-13-2024 03:35 PM
Transcript : Tandem Diabetes Care, Inc. Presents at Oppenheimer 34th Annual Healthcare MedTech & Services Conference 2024, Mar-12-2024 01:20 PM
Transcript : Tandem Diabetes Care, Inc. Presents at 45th Annual Raymond James Institutional Investors Conference 2024, Mar-06-2024 11:00 AM
Tandem Diabetes Care Shares Drop 12% After Private Placement for Senior Notes DJ
Sector Update: Health Care Stocks Steady Pre-Bell Tuesday MT
Tandem Diabetes Care Plans $250 Million Private Placement Notes -- Shares Decline After Hours MT
Transcript : Tandem Diabetes Care, Inc. Presents at TD Cowen 44th Annual Health Care Conference 2024, Mar-04-2024 01:30 PM
Transcript : Tandem Diabetes Care, Inc. Presents at Citi?s 2024 Unplugged Medtech and Life Sciences Access Day, Feb-29-2024 01:00 PM
Earnings Flash (TNDM) TANDEM DIABETES CARE Reports Q4 Revenue $196.8M, vs. Street Est of $202.8M MT
Tandem Diabetes Care, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023 CI
Transcript : Tandem Diabetes Care, Inc., Q4 2023 Earnings Call, Feb 21, 2024
Tandem Diabetes Care, Inc. Reports Earnings Results for the Fourth Quarter Ended December 31, 2023 CI
Tandem Diabetes Care Launches Tandem Mobi, the World?s Smallest, Durable Automated Insulin Delivery System CI
UBS Raises Tandem Diabetes Care Price Target to $28 From $18, Maintains Neutral Rating MT
TD Cowen Raises Tandem Diabetes Care Price Target to $35 From $22, Maintains Outperform Rating MT
Abbott Laboratories, Tandem Diabetes Care Integrate Technologies for Automated Blood Sugar Control MT
Tandem Diabetes Care's t:Slim X2 Insulin Pump Is the First Automated Insulin Delivery System to Integrate with Abbott's New Freestyle Libre 2 Plus Sensor CI
TANDEM DIABETES CARE SHARES UP 2.7% AFTER LEERINK PARTNERS RAISE… RE
Tandem Diabetes Care Launches New Diabetes Management Platform in US MT
Tandem Diabetes Care, Inc. Announces Full U.S. Launch of Tandem Source, a New Diabetes Management Platform for Customers and Healthcare Providers CI
Tandem Diabetes Care Launches Insulin Pump Software Update for Integration With Dexcom in US MT
Chart Tandem Diabetes Care, Inc.
More charts
Tandem Diabetes Care, Inc. is a global insulin delivery and diabetes technology company, which manufactures and sells advanced automated insulin delivery systems. Its pump portfolio features the Tandem Mobi system and the t:slim X2 insulin pump, both of which feature Control-IQ advanced hybrid closed-loop technology. Its t:slim X2 and Tandem Mobi pumps can be used with a variety of infusion sets to offer patients choice in how and where their pump is worn. In addition, they are software updatable from a personal computer and compatible with its Web-based data management application. Both pumps feature its Control-IQ advanced hybrid closed loop technology, with an automated insulin delivery (AID) feature designed to help increase a user's time in targeted glycemic range. There are two primary therapies used by people with insulin-dependent diabetes, Multiple Daily Injection (MDI) and insulin pumps. As part of it AID systems, it offers pump integration with multiple CGM sensors.
Calendar
More about the company
Trading Rating
Investor Rating
ESG Refinitiv
B
More Ratings
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
16
Last Close Price
30.93 USD
Average target price
34.64 USD
Spread / Average Target
+12.00%
Consensus
  1. Stock Market
  2. Equities
  3. TNDM Stock
  4. News Tandem Diabetes Care, Inc.
  5. Tandem Diabetes Care : Berenberg Bank Adjusts Tandem Diabetes Care PT to $138 From $131 on Strong Q1 Results and Improved Outlook, Maintains Buy Rating